BPC-157 20mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of BPC-157 supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF122025103

Key analytical results include:

• Assay Content: 23.2 mg
• Identification – Retention Time: 0.997
• Identification – Spectrum: 1000
• Purity: greater than 99.8 percent
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

BPC-157 is a synthetic peptide frequently studied in controlled laboratory environments focused on peptide-mediated cellular signalling and biochemical regulatory pathways.

The peptide is derived from a biologically active protein fragment originally identified within gastric peptide research models and has since been widely referenced in experimental peptide studies.

This preparation contains 20 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves molecular stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Because of its defined amino acid sequence and stable analytical profile, BPC-157 is commonly referenced in experimental peptide research models investigating cellular signalling systems.

Compound Overview

BPC-157 is a synthetic peptide consisting of a sequence derived from a protein fragment identified during gastric peptide research.

Within biochemical research environments, the compound is frequently investigated for its interaction with cellular signalling networks and peptide-mediated regulatory systems.

Laboratory studies involving this peptide often explore molecular mechanisms associated with intracellular signalling and biochemical regulatory pathways.

The defined peptide structure allows researchers to investigate peptide-mediated biochemical interactions in controlled experimental models.

Historical Background and Scientific Context

Research into synthetic peptides expanded rapidly during the late twentieth century as advances in peptide synthesis enabled scientists to replicate biologically active fragments of larger proteins.

During the 1990s and early 2000s, research interest grew in peptide fragments capable of interacting with cellular signalling systems and molecular regulatory pathways.

BPC-157 subsequently became referenced in experimental biochemical research exploring peptide-mediated signalling networks and regulatory processes.

Modern peptide research continues to investigate small signalling peptides in controlled laboratory environments to better understand intracellular biochemical pathways.

Mechanistic Focus in Research

Within experimental laboratory settings, BPC-157 is frequently studied in relation to peptide-mediated signalling pathways and intracellular regulatory systems.

Research investigations commonly explore the compound in experimental models examining:

• Peptide-receptor interaction mechanisms
• Cellular signalling pathway dynamics
• Intracellular regulatory networks
• Molecular signalling cascade modelling
• Comparative peptide interaction studies
• Peptide-mediated biochemical regulation
• Experimental signalling pathway analysis

These experimental models allow scientists to investigate molecular regulatory mechanisms influencing cellular signalling behaviour and biochemical pathway interactions.

Research Applications

In controlled research environments, BPC-157 may be utilised in experimental models designed to explore peptide signalling systems and intracellular regulatory pathways.

Examples of research applications include:

• Peptide signalling pathway investigation
• Cell signalling analysis
• Molecular regulatory pathway studies
• Intracellular signalling network modelling
• Comparative peptide research
• Experimental biochemical peptide studies
• Controlled in vitro peptide interaction research

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

Verified and analysed with Liquilabs s.r.o. (Czechia)
Validated assay content of 23.2 mg
Purity greater than 99.8 percent
Retention time and spectral identity confirmation
Endotoxin levels below 0.001 EU per mg
No detectable microbial contamination
No detectable heavy metals
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.